Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)

OBJECTIVES: We identified factors associated with thromboembolic and bleeding events in two contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with either vitamin K antagonists (VKA) or non-VKA oral anticoagulants (NOACs). DESIGN: Prospective, multicentre observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohla, Miklos, Weiss, Thomas W, Pecen, Ladislav, Patti, Giuseppe, Siller-Matula, Jolanta M, Schnabel, Renate B, Schilling, Richard, Kotecha, Dipak, Lucerna, Markus, Huber, Kurt, De Caterina, Raffaele, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475354/
https://www.ncbi.nlm.nih.gov/pubmed/30928922
http://dx.doi.org/10.1136/bmjopen-2018-022478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475354/
https://www.ncbi.nlm.nih.gov/pubmed/30928922
http://dx.doi.org/10.1136/bmjopen-2018-022478

Ejemplares similares